NCT01015339

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

A Randomized Multicenter Phase III Study Comparing Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment or Cisplatin Plus Capecitabine in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 320 (estimated)
• Sponsor: Peking University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate whether Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment as 1st line treatment in he advanced gastric cancer is effective and safe.

Conditions

• Advanced Gastric Cancer

Interventions

Type	Name	Description
DRUG	Paclitaxel	80mg/m2 infusion,d1,d8 every 3 weeks
DRUG	capecitabine	Dosing schedule: 1000mg/m2 bid, days 1-14, every 3 weeks
DRUG	capecitabine	Dosing schedule: 1000mg/m2 bid, days 1-14, every 3 weeks
DRUG	cisplatin	80mg/m2, day 1 of every 3 weeks

Timeline

• Start date: 2009-11-01
• Primary completion: 2015-08-01
• Completion: 2015-08-01
• First posted: 2009-11-18
• Last updated: 2015-05-19

Locations

1 site across 1 country: China